U.S. FDA nominee moves to untangle potential conflicts of interest

(Reuters) – Dr. Scott Gottlieb, President Donald Trump’s nominee to lead the U.S. Food and Drug Administration, has outlined measures he would take to untangle his ties to the pharmaceutical industry if confirmed by the Senate.

from Reuters: Politics http://ift.tt/2nvCBrF

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s